Skip to content
10-Q

Quarterly Report

PLx Pharma Winddown Corp.

0001437749-22-026958

← back to feed
Filed
Nov 10, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 8, 2022 29.14M sh
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$45.97M
Operating Cash Flow restated Q3 2022 · Sep 30, 2021 −$18.76M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $25.83M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $69.39M
Stockholders Equity Q3 2022 · Sep 30, 2022 $10.19M
Stockholders Equity Q3 2022 · Jun 30, 2022 $16.49M
Stockholders Equity Q3 2022 · Mar 31, 2022 $25.97M
Stockholders Equity Q3 2022 · Dec 31, 2021 $35.67M
Stockholders Equity restated Q3 2022 · Sep 30, 2021 $30.89M
Stockholders Equity restated Q3 2022 · Jun 30, 2021 $40.12M
Stockholders Equity restated Q3 2022 · Mar 31, 2021 $44.66M
Stockholders Equity restated Q3 2022 · Dec 31, 2020 −$10.93M
Current Liabilities Q3 2022 · Sep 30, 2022 $6.31M
Current Liabilities Q3 2022 · Dec 31, 2021 $11.88M
Total Liabilities Q3 2022 · Sep 30, 2022 $7.02M
Total Liabilities Q3 2022 · Dec 31, 2021 $24.96M
Current Assets Q3 2022 · Sep 30, 2022 $30.22M
Current Assets Q3 2022 · Dec 31, 2021 $73.48M
Total Assets Q3 2022 · Sep 30, 2022 $33.22M
Total Assets Q3 2022 · Dec 31, 2021 $76.64M
Eps Basic Q3 2022 · Sep 30, 2022 −$0.30
Eps Basic Q3 2022 · Sep 30, 2022 −$1.11
Eps Basic Q3 2022 · Sep 30, 2021 −$0.80
Eps Basic Q3 2022 · Sep 30, 2021 −$2.34
Sga Expense Q3 2022 · Sep 30, 2022 $9.14M
Sga Expense Q3 2022 · Sep 30, 2022 $41.24M
Sga Expense restated Q3 2022 · Sep 30, 2021 $11.01M
Sga Expense restated Q3 2022 · Sep 30, 2021 $19.15M
Rd Expense Q3 2022 · Sep 30, 2022 $623K
Rd Expense Q3 2022 · Sep 30, 2022 $1.83M
Rd Expense restated Q3 2022 · Sep 30, 2021 $1.55M
Rd Expense restated Q3 2022 · Sep 30, 2021 $3.49M
Net Income Q3 2022 · Sep 30, 2022 −$8.5M
Net Income Q3 2022 · Sep 30, 2022 −$31.14M
Net Income Q3 2022 · Jun 30, 2022 −$11.86M
Net Income Q3 2022 · Mar 31, 2022 −$10.79M
Net Income restated Q3 2022 · Sep 30, 2021 −$21.64M
Net Income restated Q3 2022 · Sep 30, 2021 −$49.69M
Net Income restated Q3 2022 · Jun 30, 2021 −$16.51M
Net Income restated Q3 2022 · Mar 31, 2021 −$11.54M
Operating Income Q3 2022 · Sep 30, 2022 −$10.84M
Operating Income Q3 2022 · Sep 30, 2022 −$43.57M
Operating Income restated Q3 2022 · Sep 30, 2021 −$9.86M
Operating Income restated Q3 2022 · Sep 30, 2021 −$19.94M
Gross Profit Q3 2022 · Sep 30, 2022 −$1.07M
Gross Profit Q3 2022 · Sep 30, 2022 −$497K
Gross Profit restated Q3 2022 · Sep 30, 2021 $2.7M
Gross Profit restated Q3 2022 · Sep 30, 2021 $2.7M
Cost Of Revenue Q3 2022 · Sep 30, 2022 $1.46M
Cost Of Revenue Q3 2022 · Sep 30, 2022 $3.45M
Cost Of Revenue restated Q3 2022 · Sep 30, 2021 $3.91M
Cost Of Revenue restated Q3 2022 · Sep 30, 2021 $3.91M